According to a leader from the pharma firm, considering a patient’s needs and seeing them as a whole person is vital to successful studies and drug design.
This year, global pharmaceutical company launched its Patient-Informed Development and Health Value translation team, an effort to ensure patient centricity is a top priority at every level of the drug development process. Victoria DiBiaso, global head of the team, discussed the patient-centric culture at the company and the importance of integrating the patient perspective throughout the pipeline.
OSP: What does it mean for pharma companies and their research partners to be truly ‘patient centric’ in their studies?